Biotech · Private company
AiViva BioPharma, Inc.
Track this companyFree. Adds AiViva BioPharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials71 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- AIV001Phase 2 · Papulopustular RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- AIV007Phase 2 · Neovascular (Wet) Age-Related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- EYLEA® (aflibercept) Injection 2 mg (0.05mL)Phase 2 · Neovascular (Wet) Age-Related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Papulopustular RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- AIV001Phase 1 · Superficial Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- AIV001Phase 1 · KeloidClinicalTrials.gov · fetched Nov 12, 2026
- AIV001Phase 1 · ScarClinicalTrials.gov · fetched Nov 12, 2026
- AIV001 suspensionPhase 1 · Superficial Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- AIV007Phase 1 · Neovascular Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- Safety and Efficacy of AIV007 Periocular Injection in Patients With Neovascular Age-Related Macular DegenerationPHASE2 · RECRUITING · started Jul 1, 2026ClinicalTrials.gov NCT07557121 · fetched Nov 12, 2026
- Effect of AIV007 by Periocular Administration in Subjects With Macular Edema Secondary to nAMD and DMEPHASE1 · COMPLETED · started Mar 2, 2023ClinicalTrials.gov NCT05698329 · fetched Nov 12, 2026
- A Safety and Efficacy Study to Evaluate RosaceaPHASE1_PHASE2 · WITHDRAWN · started Jul 1, 2021ClinicalTrials.gov NCT03883945 · fetched Nov 12, 2026
- Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following KeloidectomyPHASE1 · COMPLETED · started Jun 23, 2021ClinicalTrials.gov NCT04827875 · fetched Nov 12, 2026
- Effect of Intravitreally Administered AIV007 in Subjects With Neovascular Age-Related Macular DegenerationPHASE1 · COMPLETED · started Aug 28, 2020ClinicalTrials.gov NCT04422899 · fetched Nov 12, 2026
- Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma SubtypePHASE1 · COMPLETED · started Aug 18, 2020ClinicalTrials.gov NCT04470726 · fetched Nov 12, 2026
- A Safety and Efficacy Study to Evaluate AIV001 in Wound Healing Following Surgical IncisionPHASE1 · COMPLETED · started Nov 5, 2018ClinicalTrials.gov NCT03639883 · fetched Nov 12, 2026